Login / Signup

Effectiveness and persistence of anti-obesity medications (liraglutide 3 mg, lorcaserin, and orlistat) in a real-world primary care setting.

Sharon Leventhal-PerekMichal ShaniYochai Schonmann
Published in: Family practice (2022)
Liraglutide 3 mg was the primary medication associated with clinically significant weight loss and had the highest persistence rate in our real-world study.
Keyphrases
  • weight loss
  • primary care
  • bariatric surgery
  • metabolic syndrome
  • roux en y gastric bypass
  • insulin resistance
  • type diabetes
  • randomized controlled trial
  • healthcare
  • gastric bypass
  • emergency department
  • skeletal muscle